Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Apr 5 2018

Full Issue

With Congress' Purse Strings Newly Loosened, Pharma Poised To Make A Lot Of Money From Opioid Fight

In the fight against the national drug epidemic, there's now a larger focus on medication-based treatments. So, where should advocates draw the line in terms of working with drugmakers when it comes to conflicts of interest? Meanwhile, a new report details the cost to employers of treating opioid addiction.

Stat: Is Drug Industry Friend Or Foe? In Addiction Policy Circles, Depends Who You Ask

Increased attention to the epidemic, however, has created an undeniable business opportunity for many drug companies. A spending bill passed earlier this year added $3 billion in funding for initiatives specific to the opioid crisis. Budget caps allow for many more billions to be spent in 2020 — a significant chunk of which is destined to fund medications used to treat opioid use disorder. The bills Nickel testified about before the Energy and Commerce Committee are likely to authorize much of this spending. (Facher, 4/5)

The Associated Press: Opioid Addiction Costs Employers $2.6B A Year For Care

A new report shows large employers spent $2.6 billion to treat opioid addiction and overdoses in 2016, an eightfold increase since 2004. More than half went to treat employees' children. The analysis released Thursday by the nonpartisan Kaiser Family Foundation finds such spending cost companies and workers about $26 per enrollee in 2016. Employers have been limiting insurance coverage of opioids because of concerns about addiction. The report finds spending on opioid prescriptions falling 27 percent from a peak in 2009. (4/5)

The Hill: Study: Cost Of Treating Opioid Addiction Soars 

Opioid use on employer-based health plans peaked in 2009 with about 17.3 percent of enrollees receiving at least one prescription that year. It has since fallen to its lowest level in more than a decade — 13.6 percent, the Kaiser report shows. (Roubein, 4/5)

And in other news —

The Associated Press: Puerto Rico Sues Purdue Pharma Over Opioid Crisis

Puerto Rico's Justice Department has filed a lawsuit against Purdue Pharma accusing the drugmaker of causing an opioid crisis in the U.S. territory. Officials said Wednesday that they are seeking to hold the company responsible for all government costs incurred as a result of the damage opioids have caused. The suit also accuses the company of misrepresenting the risk of abuse and addiction, among other things. (4/4)

Wyoming Public Radio: Northern Arapaho Tribe Sues Opioid Companies

The Northern Arapaho Tribe on the Wind River Reservation has filed a lawsuit against some of the country’s biggest opioid manufacturers and distributors. The tribe says addiction to opioid medications has hit tribal communities harder than any other in the country. (Edwards, 4/4)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF